S

Active Director Director DIN 00243601
DIN 00243601 First appointment Dec 2004 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 0 historical roles
Total affiliations 2 Since Dec 2004
Shareholding value - Across - companies

About Sandhya

Sandhya has 21 years in corporate governance. Holds Director role. Currently with 2 companies, including Madhav Drugs Private Limited and Erenco (India) Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00243601
Primary Designation Director
First Appointment 07 Dec 2004
Oldest Company Age 21 yrs

Current companies

Company Designation Appointment Founded Status
Madhav Drugs Private Limited U24232DL2004PTC131016
Director 07 Dec 2004 2004 Active
Erenco (India) Limited U36997DL2017PLC319333
Director 23 Jan 2020 2017 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Madhav Drugs Private Limited
Erenco (India) Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Sandhya

Sandhya has 21 years in corporate governance. Holds Director role. Currently with 2 companies, including Madhav Drugs Private Limited and Erenco (India) Limited. Engaged in General Business. Contributes to corporate operations.

Sandhya is associated with 2 companies as Director.

Sandhya has expertise in General Business.

Sandhya has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available